Dare Bioscience, Inc. (DARE): Depreciation & Amortization
$1.63M
Year ended 2025-12-31
+23.9%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.63M | n/m | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | $42.3K | n/a | 2026-03-26, From 2024-01-01 |
| No annual figure between 2016-12-31 and 2024-12-31. | |||
| 2016-12-31 | $261.0K | +35.9% | 2017-06-13, From 2016-01-01 |
| 2015-12-31 | $192.0K | +52.4% | 2017-06-13, From 2015-01-01 |
| 2014-12-31 | $126.0K | -36.0% | 2017-06-13, From 2014-01-01 |
| 2013-12-31 | $197.0K | -43.1% | 2016-03-10, From 2013-01-01 |
| 2012-12-31 | $346.0K | n/a | 2015-03-19, From 2012-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $1.63M | n/m |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $43.3K | +269.5% |
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | $3.70M | -2.6% |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | $73.7K | -10.5% |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $288.0K | +28.0% |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | $663.0K | 0.0% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $800.0K | +14.3% |
| Rallybio Corp (RLYB) | 2025-12-31 | $92.0K | -29.8% |
| Vistagen Therapeutics, Inc. (VTGN) | 2026-03-31 | $199.0K | +32.7% |
Compare DARE, SXTP, STTK, SXTC side by side · Screen every company in Pharmaceutical Preparations ↗